VPS35 Gene and Parkinson's Disease

Parkinson’s disease (PD) is a progressive condition that affects the nervous system, particularly the part of the brain responsible for movement. Whilst PD has no known cause, it has previously been linked to mutations in the VPS35 gene.

Neurons that are affected in Parkinson

KateStudio | Shutterstock

Parkinson’s disease is a neurodegenerative condition that affects the dopamine-producing brain cells in the brain area dubbed as the substantia nigra. The disease leads to various movement problems, including tremor, limb or muscular rigidity, bradykinesia, imprecise movements, and gait or balance problems.

An estimated 10 million people are living with Parkinson’s disease across the globe. In the United States, about one million people have the disease, with 60,000 Americans being diagnosed each year. However, some patients go undiagnosed until advanced stages of disease are present.

Men have a 50% higher risk of developing the disease compared with women. In most cases, symptoms begin after the age of 50 years. However, 4% to 5% of patients experience symptoms before the age of 40. When the symptoms appear between the ages of 21 and 40, it is referred to as Young-onset Parkinson’s disease.

Parkinson’s disease etiology

To understand Parkinson’s disease, it is important to understand how neurons work. The brain controls all processes in the human body. Nerve cells (neurons) send and receive nerve impulses between the brain and all parts of the body. These impulses, or messages, help the body communicate with the brain as its control center.

The neurons contain dendrites, which are branching arms. They serve as antennae to pick up signals and messages. Once a message is received, the neuron’s axon carries the messages away from the body of the cell. In this way, nerve impulses travel through neurons, from the axon of one nerve cell to the dendrites of the next.

The travel of the messages from one neuron to another is made possible, thanks to a tiny gap between them called a synapse. For a message to cross the gap, neurotransmitters (chemical messengers) are needed.

In people with Parkinson’s disease, there is an abnormally low level of dopamine, which is one of these chemical messengers that sends signals around the body to control movement. The low dopamine levels in Parkinson’s disease result from death of dopaminergic neurons, a type of nerve cells, in the substantia nigra.

When there are low levels of dopamine, people find it difficult to control their movements, including simple activities like walking.

How is VPS35 involved in Parkinson’s disease?

Aside from environmental and genetic factors associated with the development of Parkinson’s, gene mutations have appear to play an important role in the progression of this neurodegenerative disease.

Recently, a new gene has been associated with PD. Identification of the VPS35, or vacuolar protein sorting 35 homolog, gene has provided new insights into the disease process involved in PD. Various studies have shown that the VPS35 gene is associated with late-onset, autosomal dominant familial Parkinson’s disease.

Autosomal dominant inheritance is also seen with alpha-synuclein-SNCA and LRRK2 genes, which have also been associated with PD. Autosomal recessive inheritance of Parkin, DJ1, or PINK1 genes has also been associated with PD.

Although the exact mechanism by which PD develops remains unclear, understanding more about the gene can lead to the development of proper therapeutic strategies.

Connecting Parkinson's Disease Gene Functions

Further Reading

Last Updated: Nov 15, 2018

Angela Betsaida B. Laguipo

Written by

Angela Betsaida B. Laguipo

Angela is a nurse by profession and a writer by heart. She graduated with honors (Cum Laude) for her Bachelor of Nursing degree at the University of Baguio, Philippines. She is currently completing her Master's Degree where she specialized in Maternal and Child Nursing and worked as a clinical instructor and educator in the School of Nursing at the University of Baguio.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Laguipo, Angela. (2018, November 15). VPS35 Gene and Parkinson's Disease. News-Medical. Retrieved on July 13, 2024 from https://www.news-medical.net/health/VPS35-Gene-and-Parkinsons-Disease.aspx.

  • MLA

    Laguipo, Angela. "VPS35 Gene and Parkinson's Disease". News-Medical. 13 July 2024. <https://www.news-medical.net/health/VPS35-Gene-and-Parkinsons-Disease.aspx>.

  • Chicago

    Laguipo, Angela. "VPS35 Gene and Parkinson's Disease". News-Medical. https://www.news-medical.net/health/VPS35-Gene-and-Parkinsons-Disease.aspx. (accessed July 13, 2024).

  • Harvard

    Laguipo, Angela. 2018. VPS35 Gene and Parkinson's Disease. News-Medical, viewed 13 July 2024, https://www.news-medical.net/health/VPS35-Gene-and-Parkinsons-Disease.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Efficacy of acupuncture in improving sleep quality for Parkinson's patients